Ibuprofen Suspension
NDC 70518-4595
Product Information
Ibuprofen is a ANDA-approved product labeled by Remedyrepack Inc.. Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. It is supplied as a white suspension for oral administration. This product entry covers the primary NDC 70518-4595 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
Code Structure Chart
Product Details
What is NDC 70518-4595?
What are the uses of this product?
What are Active Ingredients of this product?
- IBUPROFEN 100 mg/5mL - A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- IBUPROFEN (UNII: WK2XYI10QM)
- IBUPROFEN (UNII: WK2XYI10QM) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ACESULFAME POTASSIUM (UNII: 23OV73Q5G9)
- ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
- GLYCERIN (UNII: PDC6A3C0OX)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- SODIUM BENZOATE (UNII: OJ245FE5EU)
- WATER (UNII: 059QF0KO0R)
- SUCROSE (UNII: C151H8M554)
- XANTHAN GUM (UNII: TTV12P4NEE)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 197803 - ibuprofen 100 MG in 5 mL Oral Suspension
- RxCUI: 197803 - ibuprofen 20 MG/ML Oral Suspension
- RxCUI: 197803 - ibuprofen 100 MG per 5 ML Oral Suspension
- RxCUI: 197803 - ibuprofen 200 MG per 10 ML Oral Suspension
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.